当前位置:首页 - 行情中心 - 广济药业(000952) - 财务分析 - 现金流量表

广济药业

(000952)

  

流通市值:22.15亿  总市值:22.15亿
流通股本:3.44亿   总股本:3.44亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金392,627,448.77189,602,012.29625,750,089.99469,573,025.71
  收到的税费返还5,564,917.761,894,305.0818,328,274.5117,569,623.07
  收到其他与经营活动有关的现金7,404,776.023,293,891.8422,833,757.3216,937,174.31
  经营活动现金流入小计405,597,142.55194,790,209.21666,912,121.82504,079,823.09
  购买商品、接受劳务支付的现金253,376,914.48109,518,211.1368,682,133.41273,002,990.07
  支付给职工以及为职工支付的现金59,783,657.5629,676,947.78127,488,327.88100,547,667.92
  支付的各项税费14,696,871.627,958,421.8229,952,433.9920,082,458.15
  支付其他与经营活动有关的现金34,011,643.5114,863,202.5380,361,248.4562,803,799.88
  经营活动现金流出小计361,869,087.17162,016,783.23606,484,143.73456,436,916.02
  经营活动产生的现金流量净额43,728,055.3832,773,425.9860,427,978.0947,642,907.07
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,000,0001,000,0004,998,030-
  处置子公司及其他营业单位收到的现金净额--55,437,259.455,437,259.4
  投资活动现金流入小计1,000,0001,000,00060,435,289.455,437,259.4
  购建固定资产、无形资产和其他长期资产支付的现金4,652,771.482,696,249.1535,640,557.3332,342,774.54
  投资活动现金流出小计4,652,771.482,696,249.1535,640,557.3332,342,774.54
  投资活动产生的现金流量净额-3,652,771.48-1,696,249.1524,794,732.0723,094,484.86
三、筹资活动产生的现金流量:
  取得借款收到的现金570,467,949.05386,295,813.8742,684,602.95558,338,210.76
  筹资活动现金流入小计570,467,949.05386,295,813.8742,684,602.95558,338,210.76
  偿还债务支付的现金594,797,853.29357,864,751.76794,815,725.64622,756,521.74
  分配股利、利润或偿付利息支付的现金21,840,333.1210,610,925.4750,946,079.4538,436,982.82
  支付其他与筹资活动有关的现金9,928,914336,86422,348,86922,880,354.72
  筹资活动现金流出小计626,567,100.41368,812,541.23868,110,674.09684,073,859.28
  筹资活动产生的现金流量净额-56,099,151.3617,483,272.57-125,426,071.14-125,735,648.52
四、汇率变动对现金及现金等价物的影响-2,243,235.62-812,194.26784,310.61827,636.97
五、现金及现金等价物净增加额-18,267,103.0847,748,255.14-39,419,050.37-54,170,619.62
  加:期初现金及现金等价物余额267,758,214.81267,758,214.81307,177,265.18307,177,265.18
  期末现金及现金等价物余额249,491,111.73315,506,469.95267,758,214.81253,006,645.56
补充资料:
  净利润-61,901,634.85--438,947,124.55-
  资产减值准备2,996,388.8-299,848,489.13-
  固定资产和投资性房地产折旧64,609,861.77-153,470,396.13-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧64,609,861.77-153,470,396.13-
  无形资产摊销2,889,548.63-6,183,592.65-
  长期待摊费用摊销851,037.94-1,792,091.13-
  处置固定资产、无形资产和其他长期资产的损失-5,903,843.56--549,256.12-
  固定资产报废损失149.16-206,983.94-
  财务费用21,715,071.11-51,155,779.37-
  投资损失668,417.79--18,384,643.69-
  递延所得税753,385.52--4,187,763.87-
  其中:递延所得税资产减少721,999.15--4,046,754.67-
    递延所得税负债增加31,386.37--141,009.2-
  存货的减少18,522,119.96-47,794,118.85-
  经营性应收项目的减少6,974,938.63--118,473,819.77-
  经营性应付项目的增加-4,039,709.51-90,632,735.71-
  其他-4,771,592.74--10,745,876.98-
  现金的期末余额249,491,111.73-267,758,214.81-
  减:现金的期初余额267,758,214.81-307,177,265.18-
  现金及现金等价物的净增加额-18,267,103.08--39,419,050.37-
公告日期2026-08-282026-04-252026-04-252025-10-27
审计意见(境内)标准无保留意见
TOP↑